Titelia

Funds holding BIOPHARMA CREDIT PLC

1 fund declares a position · 0 ETFs and 1 other funds · 10.4M $ · GB00BDGKMY29

Each line carries its report date.

FundSharesValueWeight
BNY Mellon Global Real Return Fund BNY Mellon Advantage Funds, Inc. 11,018,59210.4M $1.21 %as of Apr 30, 2026 · Original filing